1: Peng HL, Zhang GS, Liu JH, Gong FJ, Li RJ. Dup-697, a specific COX-2 inhibitor, suppresses growth and induces apoptosis on K562 leukemia cells by cell-cycle arrest and caspase-8 activation. Ann Hematol. 2008 Feb;87(2):121-9. doi: 10.1007/s00277-007-0385-4. Epub 2007 Nov 13. PMID: 17999062.
2: Altun A, Turgut NH, Kaya TT. Anticancer effect of COX-2 inhibitor DuP-697 alone and in combination with tyrosine kinase inhibitor (E7080) on colon cancer cell lines. Asian Pac J Cancer Prev. 2014;15(7):3113-21. doi: 10.7314/apjcp.2014.15.7.3113. PMID: 24815456.
3: Rosenstock M, Danon A, Rimon G. PGHS-2 inhibitors, NS-398 and DuP-697, attenuate the inhibition of PGHS-1 by aspirin and indomethacin without altering its activity. Biochim Biophys Acta. 1999 Aug 25;1440(1):127-37. doi: 10.1016/s1388-1981(99)00105-5. PMID: 10477832.
4: Churchman A, Baydoun AR, Hoffman R. Inhibition of angiogenic tubule formation and induction of apoptosis in human endothelial cells by the selective cyclooxygenase-2 inhibitor 5-bromo-2-(4-fluorophenyl)-3-(methylsulfonyl) thiophene (DuP-697). Eur J Pharmacol. 2007 Nov 14;573(1-3):176-83. doi: 10.1016/j.ejphar.2007.06.057. Epub 2007 Jul 7. PMID: 17643408.
5: Burdan F, Dudka J, Szumilo J, Korobowicz A, Klepacz L. Prenatal effects of DuP-697-the irreversible, highly selective cyclooxygenase-2 inhibitor. Reprod Toxicol. 2003 Jul-Aug;17(4):413-9. doi: 10.1016/s0890-6238(03)00045-5. PMID: 12849852.
6: Gans KR, Galbraith W, Roman RJ, Haber SB, Kerr JS, Schmidt WK, Smith C, Hewes WE, Ackerman NR. Anti-inflammatory and safety profile of DuP 697, a novel orally effective prostaglandin synthesis inhibitor. J Pharmacol Exp Ther. 1990 Jul;254(1):180-7. PMID: 2366180.
7: Kaya TT, Altun A, Turgut NH, Ataseven H, Koyluoglu G. Effects of a Multikinase Inhibitor Motesanib (AMG 706) Alone and Combined with the Selective DuP-697 COX-2 Inhibitor on Colorectal Cancer Cells. Asian Pac J Cancer Prev. 2016;17(3):1103-10. doi: 10.7314/apjcp.2016.17.3.1103. PMID: 27039732.
8: de Vries EF, van Waarde A, Buursma AR, Vaalburg W. Synthesis and in vivo evaluation of 18F-desbromo-DuP-697 as a PET tracer for cyclooxygenase-2 expression. J Nucl Med. 2003 Oct;44(10):1700-6. PMID: 14530489.
9: Agarwal V, Hodgkinson VC, Eagle GL, Scaife L, Lind MJ, Cawkwell L. Proteomic (antibody microarray) exploration of the molecular mechanism of action of the specific COX-2 inhibitor DuP 697. Int J Oncol. 2013 Mar;42(3):1088-92. doi: 10.3892/ijo.2013.1784. Epub 2013 Jan 22. PMID: 23338544.
10: Joshi AS, Raghavan N, Williams RM, Takahashi K, Shingu H, King SY. Simultaneous quantification of an anti-inflammatory compound (DuP 697) and a potential metabolite (X6882) in human plasma and urine by high-performance liquid chromatography. J Chromatogr B Biomed Appl. 1994 Oct 3;660(1):143-50. doi: 10.1016/0378-4347(94)00272-x. PMID: 7858707.